-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

PNH: Key Clinical Considerations for a Terminal Complement-Mediated Disease

Sponsor: Alexion Pharmaceuticals
Program: Product Theaters
Monday, December 7, 2020: 10:30 AM-11:30 AM
PNH: Key Clinical Considerations for a Terminal Complement-Mediated Disease

Anita Hill, MD, PhD

Alexion Pharmaceuticals, Inc., Leeds, United Kingdom
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>